DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Rini BI, Plimack ER, Stus V. et al.
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
New England Journal of Medicine 2019;
380: 1116-1127
DOI: 10.1056/NEJMoa1816714.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.